Elsevier

Neuroscience Letters

Volume 212, Issue 2, 12 July 1996, Pages 123-126
Neuroscience Letters

Determination of the cannabinoid receptors in mouse × rat hybridoma NG108-15 cells and rat GH4C 1 cells

https://doi.org/10.1016/0304-3940(96)12792-0Get rights and content

Abstract

The cannabinoid receptors expressed in the mouse neuroblastoma × rat glioma NG108-15 cell and the rat pituitary tumor GH4C1 cell were determined by polymerase chain reaction, dideoxysequencing and pharmacologically. The CBI but not the C132 or CB1A cannabinoid receptor was found in both cell lines. The cDNA identified in GH4C1 cells corresponds to the rat CB 1 receptor. Interestingly, NG108-15 cells express two distinct cDNAs, one corresponds to the rat and the other to the mouse CB1 receptor. The newly developed CB1 receptor selective antagonist SR141716A was found to reverse cannabinoid agonist (WIN55212-2 or CP55940)-induced adenylyl cyclase inhibition. These results provide more direct evidence that the CB 1 receptor is mediating the pharmacological actions of cannabinoids in NG108-15 and GH4C1 cells.

References (18)

There are more references available in the full text version of this article.

Cited by (16)

  • CB<inf>1</inf> and CB<inf>2</inf> Receptor Pharmacology

    2017, Advances in Pharmacology
    Citation Excerpt :

    The rat and human receptors are highly conserved, 93% identity at the nucleic acid level and 97% at the amino acid level. Similarly, the mouse and rat clones have 95% nucleic acid identity (100% amino acid identity) and the mouse and human clones have 90% nucleic acid identity (97% amino acid identity) (Abood, Ditto, Noel, Showalter, & Tao, 1997; Chakrabarti, Onaivi, & Chaudhuri, 1995; Ho & Zhao, 1996). A meta-analysis of the literature examining cannabinoid ligand-binding affinity revealed subtle interspecies differences for the binding affinities of some ligands (Δ9-THC, CP55,940, WIN55,212-2, SR141716A) for rat vs human CB1 receptors (McPartland, Glass, & Pertwee, 2007).

  • Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids

    2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry
    Citation Excerpt :

    Another patient presented with emesis, agitation, mydriasis, mild tachycardia and seizure activity one hour after smoking SpicyXXX (Simmons et al., 2011b). Importantly, in NG 108‐15 cells, a cell line expressing functional cannabinoid receptors (Ho and Zhao, 1996; Matsuda et al., 1990), the synthetic cannabinoids CP-55,940, CP-47,497 and CP-47,497-C8 have been recently found to be cytotoxic, as they induced apoptosis in a dose-dependent manner likely activating the caspase cascade and involving CB1 receptors, but not CB2 receptors (Tomiyama and Funada, 2011). While the acute adverse effects of synthetic cannabinoids are recognized and documented, there is no information about the chronic use and toxicity of synthetic cannabinoids.

  • Cannabinoid receptors: Nomenclature and pharmacological principles

    2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry
    Citation Excerpt :

    The rat and human receptors are highly conserved, 93% identity at the nucleic acid level and 97% at the amino acid level. Similarly, the mouse and rat clones have 95% nucleic acid identity (100% amino acid identity) and the mouse and human clones have 90% nucleic acid identity (97% amino acid identity) (Abood et al., 1997; Chakrabarti et al., 1995; Ho and Zhao, 1996). A molecular phylogenetic analysis which included the CB1 receptor showed that the sequence diversity in 62 mammalian species varied from 0.41 to 27% (Murphy et al., 2001).

  • Cytotoxicity of synthetic cannabinoids found in "Spice" products: The role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line

    2011, Toxicology Letters
    Citation Excerpt :

    In the current study, we examined the cytotoxicity of CP-47,497 and CP-47,497-C8, which are detected in “Spice”, as well as the cytotoxicity of CP-55,940, which is a compound in which substitutions have been made at position C-4 of the cyclohexanol ring of CP-47,497, using a neuroblastoma-glioma hybrid cell line, NG 108-15. The NG 108-15 cell line was used for these studies since it is known to express functional cannabinoid receptors (Ho and Zhao, 1996; Matsuda et al., 1990). Endogenous expression of cannabinoid receptors in these cells allows investigation of whether activation of these receptors can directly regulate synthetic cannabinoid-induced cytotoxicity.

  • Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide

    2011, Journal of Biological Chemistry
    Citation Excerpt :

    In addition, pretreatment with U73122, a phospholipase C (PLC) inhibitor (29), reduced but did not abolish the Ca2+ response to anandamide (Fig. 6C). Next, to validate our results obtained in CB1 receptor-transfected cells in endogenously expressing cells, we carried out calcium imaging experiments in NG108-15 cells, which endogenously express CB1 but not CB2 receptors (17). In NG108-15 cells, extracellular administration of anandamide did not produce a significant increase in [Ca2+]i, whereas the administration of ATP (10 μm) increased [Ca2+]i by 432 ± 57 nm (n = 52) (Fig. 7).

View all citing articles on Scopus

Accession numbers for the mouse and rat CB 1 receptors are u40709 and u40395.

View full text